Martha M. Rumore, PharmD, JD, MS, LLM, FAPhA is Of Counsel at Health Law Alliance and a registered U.S. Patent Attorney

Frequently Asked Questions

Our client, an Illinois pharmacy, was targeted by a major PBM with cease-and-desist notices that alleged violations of the Provider Manual. Although the pharmacy responded to the PBM in an attempt to address the allegations, the PBM terminated the pharmacy anyway. At that point, the pharmacy retained our firm, and we immediately sprung into action to reverse the impending termination on short notice.

Successful PBM Appeals Often Require Legal Advocacy

Throughout the appeal process, HLA's experienced healthcare defense attorneys meticulously presented documentation and legal analysis that systematically addressed the PBM's alleged violations and demonstrated that either no violation occurred, or that any violation was an isolated error that did not support termination. Specifically, we combine our arguments on the facts with extensive legal research and analysis demonstrating why the PBM is not entitled to terminate the agreement at issue under relevant federal, state, and common law.

HLA's Legal Methods are Tailored to Each Case

Our method for approaching these cases is to present the client's narrative and facts in a convincing and compelling fashion, relying on our subject matter expertise, to explain why vague statements in a manual do not prohibit or apply to the facts at issue. In addition, it is important to address the PBM's concern that the conduct at issue not recur. Accordingly, because our firm employs the former Chief Compliance Officer of United Health Group, we are in a position to recommend tailored compliance strategies that the PBMs will accept in mitigation.

As part of our work in this case, our healthcare compliance specialists implemented new standard operating procedures, updated policies, and retrained staff, convincing the PBM to reinstate the pharmacy based on improved compliance protocols. This often tips the balance towards reinstatement.

Network Termination Can be Avoided

We work on many network appeals, so we can be efficient in budgeting to achieve desirable results. In this case, the pharmacy was about to be sold to a new owner, and the network termination obviously destroyed a lot of that value. By winning network reinstatement on appeal, we were able to dramatically increase the owner's return on investment. Nonetheless, if you are at risk of termination, the earlier you involve qualified counsel, the better. We are always available to help.

MORE ARTICLES BY CATEGORY

Get a Free Consultation

100% Confidential & Secure. Your details are safe with us.

We'll speak soon!

In the meantime, why not find out more about us or visit our blog.

Alternatively, give us a call at (800) 345 - 4125

Oops! Something went wrong while submitting the form.

OMIG Audit Defense New York: What the 2026 Work Plan Means for Providers

Every year, the New York Office of the Medicaid Inspector General (OMIG) releases its Work Plan outlining enforcement priorities. The 2026 plan sends a clear signal that Medicaid providers in New York are entering a far more aggressive enforcement environment.

Read More >>

PBM Member Denial Audit Findings: A Growing Threat to Pharmacies

Pharmacies undergoing a Pharmacy Benefit Manager (PBM) audit are typically prepared to address inventory discrepancies and documentation issues. What many are not prepared for, however, is the increasing use of PBM member denial findings, allegations that a patient claims they did not receive and/or did not authorize the dispensing of a medication for which a claim was submitted.

Read More >>

From Minor PBM Audit Finding to Major Liability: How Small Issues Trigger Big Consequences

Pharmacies often approach a PBM audit with the understanding that small discrepancies and modest recoupments are simply part of doing business. In today’s enforcement landscape, that assumption is no longer safe.

Read More >>

HLA’s Latest PBM Win Highlights the Dangers of Inventory Discrepancies

Inventory discrepancies are one of the first things PBMs look for during an audit. Even minor clerical errors like entering the incorrect NDC or failing to return a medication to stock can snowball, creating major financial risks that could place your pharmacy in jeopardy.

Read More >>